Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 95
Appendix B
Biographies
SPEAKER AND DISCUSSANT BIOGRAPHIES
Sonia Angell, MD, MPH, provides leadership for global noncommunicable
disease strategy, policy, and program development at the U.S. Centers for
Disease Control and Prevention (CDC). She has particular expertise in
environmental and clinical care systems policy, programming, and evalua-
tion designed to reduce chronic disease risk. Dr. Angell recently joined the
CDC, coming from the New York City Department of Health and Mental
Hygiene where she directed the Cardiovascular Disease Prevention and
Control Program. Some of her program’s key accomplishments included
regulating the use of trans fat in New York City restaurants, the National
Salt Reduction Initiative, establishing nutrition standards for food procured
by New York City government agencies, and clinical quality improve-
ment initiatives for blood pressure and cholesterol control. She received
her medical degree from the University of California, San Francisco, and
completed internal medicine residency training at Brigham and Women’s
Hospital in Boston. She has a diploma in tropical medicine and hygiene
from the London School of Hygiene and Tropical Medicine, and a master’s
in public health from the University of Michigan. She is a fellow of the
American College of Physicians. She is a former Robert Wood Johnson
clinical scholar.
Gene Bukhman, MD, PhD, is an assistant professor of medicine and an
assistant professor of global health and social medicine at Harvard Medi-
cal School. He is a cardiologist in the Division of Global Health Equity at
95
OCR for page 96
96 COUNTRY-LEVEL DECISION MAKING
Brigham and Women’s Hospital and in the Boston VA Healthcare System.
By training, Dr. Bukhman is a medical anthropologist and a cardiologist
with special competence in echocardiography. He is the cardiology director
for Partners In Health. Dr. Bukhman is an expert on strategic planning for
non-communicable disease control and serves as the senior technical advi-
sor on noncommunicable disease to the Rwandan Ministry of Health. His
research has focused on the political and historical context of intervention
in this area, as well as the evaluation of programmatic outcomes. He has
worked in Rwanda since 2006. In 2010 Dr. Bukhman was appointed as the
director of the Program in Global Non-Communicable Disease and Social
Change at Harvard Medical School.
Arun Chockalingam, MS, PhD, FACC, FAHA, leads the Office of Global
Health at the U.S. National Heart, Lung, and Blood Institute. Prior to this
appointment, Dr. Chockalingam was the founding director of the Global
Health Program and subsequently served in an enhanced role as the direc-
tor of continuing public health education at the Faculty of Health Sciences
at the Simon Fraser University, Vancouver, Canada. He received his PhD
in cardiac cell physiology and pharmacology from Memorial University
of Newfoundland. In addition, he has an extensive and varied career in
cardiovascular epidemiology, prevention, government research administra-
tion, and global health. Dr. Chockalingam served as senior policy advisor,
Centre for Chronic Disease Prevention and Control, Health Canada, and
associate director of the Institute of Circulatory and Respiratory Health
in the Canadian Institutes of Health Research, and he currently serves as
secretary general of the World Hypertension League. He has published
more than 150 papers and 11 book chapters, served as an editorial board
member and reviewer for numerous journals. He has been a reviewer for a
number of national and international research granting agencies. He was
a member of the authoring committee of the Institute of Medicine’s 2010
report Promoting Cardiovascular Health in the Developing World. He is
passionate about promoting healthy lifestyles and preventing chronic non-
communicable diseases throughout the world.
Thomas A. Gaziano, MD, MSc, is an assistant professor of medicine at
Harvard Medical School and the Harvard School of Public Health. His
research interests are in the treatment of cardiovascular disease in devel-
oping countries, including the epidemiology and management of its risk
factors and the development of decision analytic models to assess the cost-
effectiveness of various screening, prevention, and management decisions.
He has served as a consultant and author for the Disease Control Priorities
Project of the World Bank, World Health Organization, and the Fogarty In-
OCR for page 97
97
APPENDIX B
ternational Center. He is the co-principal investigator of the United Health
and U.S. National Heart, Lung, and Blood Institute collaborating center of
excellence at the University of Cape Town, where he holds an honorary se-
nior lectureship. He is co-leader of the Chronic and Cardiovascular Disease
Working Group at the Harvard Institute for Global Health. He is certified
as a diplomat in internal medicine and cardiovascular diseases.
Amanda Glassman, MSc, is the director of the Global Health Policy Pro-
gram at the Center for Global Development. She has 20 years of experi-
ence working on health and social protection policy and programs in Latin
America and elsewhere in the developing world. Prior to her current posi-
tion, Glassman was principal technical lead for health at the Inter-American
Development Bank, where she led health economics and financing knowl-
edge products and policy dialogue with member countries, and was team
leader of the Oportunidades conditional cash transfer program. She was
also a nonresident fellow at the Brookings Institution. From 2005 to 2007,
Glassman was deputy director of the Global Health Financing Initiative at
Brookings and carried out policy research on aid effectiveness and domestic
financing issues in the health sector in low-income countries. Before joining
the Brookings Institution, Glassman designed, supervised, and evaluated
health and social protection loans at the Inter-American Development Bank
and worked as a Population Reference Bureau fellow at the U.S. Agency
for International Development. Glassman holds an MSc from the Harvard
School of Public Health and a BA from Brown University, has published
on a wide range of health and social protection finance and policy topics,
and is editor and co-author of the books From Few to Many: A Decade of
Health Insurance Expansion in Colombia (IDB and Brookings, 2010) and
The Health of Women in Latin America and the Caribbean (World Bank,
2001).
Mireille Goetghebeur, PhD, received an engineering diploma and a PhD in
biochemistry from the University of Montpellier in France. Co-founder of
BioMedCom, a consulting group specializing in applied research based in
Montreal, Canada, she has worked since the mid-1990s at generating and
synthesizing data to support evidence-based decision making for health
care interventions in numerous therapeutic contexts. Her current research
interests focus on developing multi-criteria decision analysis–based tools,
processes, and databases to advance health care decision making and prior-
ity setting internationally. Principal investigator in the development of the
EVIDEM framework, she currently serves as president for the EVIDEM
Collaboration. Mireille is also an associate member of the research center
of Ste. Justine University Hospital Center in Montreal.
OCR for page 98
98 COUNTRY-LEVEL DECISION MAKING
Meenu Hariharan, MD, DM, presently the director and chief executive of-
ficer of the Indian Institute of Diabetes (a joint venture of the government
of Kerala and World-India Diabetes Foundation) and state nodal officer of
the National Program for the Prevention and Control of Diabetes, Cardio-
vascular Diseases and Stroke, possesses an illustrious career and academic
accomplishments. Formerly the director of medical education, Kerala state,
India, she is now professor emeritus at the Government Medical College,
Trivandrum, and consultant gastroenterologist. A gold medalist in MBBS,
her postgraduate qualifications include an MD in internal medicine and
doctorate (DM) in gastroenterology. Her major attainments during her
career in government include the certificate of appreciation from the gov-
ernment of Kerala for disaster management after the 2004 tsunami, and
the Best Doctor Award 2007, Kerala State, by the government of Kerala.
The major thrust of her field of research interest lies in pancreatic diabe-
tes (tropical pancreatitis), a disease almost endemic to Kerala, for which
she has had international collaboration with INSERM in France and the
Naro Cancer Center in Japan. She has since broadened her perspectives
in research to include the awareness, prevention, and control of diabetes,
cardiovascular diseases, and stroke under the aegis of the national control
program for the same, stoking many ongoing research projects, and has
conducted 245 detection and awareness camps so far, screening 24,540
members of the populace.
Emma Herry-Thompson, MD, has been in the health care arena for the
past 40 years. Thirteen of those years were spent as a registered nurse.
She received her nursing diploma in London, England. Her BSc degree
was obtained from the University of Tennessee. She was a 1984 graduate
of James H. Quillen College of Medicine, East Tennessee State University.
She completed post-graduate training in internal medicine and practiced
in four U.S. states and Washington, DC, before returning to Grenada after
a 32-year absence in January 1998. Dr. Herry-Thompson currently holds
the position of chief medical officer, a position she has held for the past 32
months. She also continues to keep a limited internal medicine practice.
Prior to joining the public system, she was director of medical education
for St. George’s University’s clinical teaching unit for 5 years.
Shah Monir Hossain, MBBS, MPhil, MPH, FCPS, is now working as
consultant to Program Preparatory Cell (PPC) of the Ministry of Health
and Family Welfare of Bangladesh. He worked with the government of
Bangladesh for 33 years in different academic and executive position. His
last assignment was director general of health services of Bangladesh, and
he was responsible for policy making, strategy development, and supervis-
ing the national health program as chief executive for implementing health
OCR for page 99
99
APPENDIX B
sector program. He provided results-oriented guidance to effectively plan,
organize, implement, manage and coordinate public health activities and
human resources in the public sector. At present he is providing technical
assistance to prepare a program implementation plan (PIP) for the health
sector program for the next 5 years. One of the major components of the
PIP is noncommunicable diseases where a strategy and interventions with
targeted indicators have been designed to improve the quality of services
in both rural and urban setting. Prof. Hossain is also involved in teaching
health service management in the Department of Public Health of North
South University, Dhaka, Bangladesh.
Antonio Infante, MD, MPH, spent the majority of his career in the Chil-
ean National Health Service. He began as a general practitioner, and then
as a public health specialist he directed primary health care (PHC) clinics;
the PHC in a health district; the department of health in Santiago, Chile’s
capital; and the North District of Health in Santiago. He also worked in
the Ministry of Health in the nutrition area (food programs), in the health
reform project, and in the management of health care. Finally, he was un-
dersecretary of health. He also has had experience in the educational sector
as advisor in the school feeding program and then as chief of the National
Students Welfare Agency. He was consultant to the United Nations and to
multilateral agencies in Latin America, Africa, and East Europe.
Tracey Pérez Koehlmoos, PhD, MHA, is the head of the Health & Family
Planning Systems Programme, at ICDDR,B. Dr. Koehlmoos is a health sys-
tems scientist who specializes in managing complex tasks, program develop-
ment, and capacity building across the spectrum of health systems building
blocks. She has lived and worked in Pakistan, Nepal, Bangladesh, and
Indonesia for more than 15 years. Her research areas of interest include the
very upstream area of developing health service delivery for the homeless in
urban Bangladesh to the downstream translation of evidence to policy with
the Ministry of Health and Family Welfare. She heads the national scale-up
of zinc (SUZY Project) and is the team leader of the Centre for Systematic
Review at ICDDR,B, which focuses on health systems and policy reviews
of non-state sector issues in low- and middle-income countries. She founded
the Centre for Control of Chronic Diseases in Bangladesh, which features
a unique health-systems approach to the issue of noncommunicable disease
in resource-poor settings. She is an adjunct professor at the James P. Grant
School of Public Health at BRAC University and in the College of Health
and Human Services at George Mason University. Her publications appear
in the Lancet, PLoS Medicine, the Cochrane Library, and Health Policy
among others. She blogs for the British Medical Journal. At ICDDR,B she
is co-founder of the Women Scientists and Researchers’ Forum and serves
OCR for page 100
100 COUNTRY-LEVEL DECISION MAKING
on the scientific council. Her consultancies include the World Food Pro-
gramme, the World Bank, and the World Health Organization.
E. Francis Martin, MD, MPH, is a graduate of St. George’s University and
works in the emergency room at the General Hospital. Dr. Martin has a
profound interest in primary health care, advocating for health promotion
as pivotal to disease prevention. He has committed himself to the cause of
healthy living by recommending lifestyle changes, helping people to connect
the dots that link behavior to diseases. Dr. Martin also conducted research
on the effects of Sahara dust on asthma visits to the emergency room in
Grenada, the abstract of which was accepted by the American Thoracic
Society for its May 2011 international conference. Dr. Martin published the
article “A community approach and involvement in primary health care”
in the Grenada Medical Journal. Presently Dr. Martin is spearheading the
primary health care revitalization program in Grenada.
Montserrat Meiro-Lorenzo, MD, MPH, MPP, is a senior public health
specialist. She is responsible for the dialogue on noncommunicable diseases
at the World Bank’s Health Nutrition and Population group. She has more
than 20 years’ experience in international health and development in Africa,
Latin America, and East Asia, ranging from clinical care to health services
management and public policy dialogue. She has designed and managed
programs and projects in areas that include hospital care, tuberculosis con-
trol, health information systems, primary health care, nutrition, HIV/AIDS,
results-based financing, and public health insurance. She holds a medical
degree and master’s degrees in both public health and public policy.
Andrew Mirelman, MPH, is a current PhD candidate in the International
Health Department at the Johns Hopkins Bloomberg School of Public
Health (JHSPH). His research interests are in applied demographic and
economic techniques for public health, specifically, economic evaluation
of noncommunicable disease prevention, rational decision-making, and
methods for assessing economic impacts. Mr. Mirelman graduated in 2009
with an MPH from JHSPH, conducting a thesis project in Lima, Peru on
national-level decision making for immunization introductions. He has
continued his work with the International Vaccine Access Center group at
JHSPH, working on their economics team. Current dissertation-level work
is being conducted on the economic impact of chronic diseases and associ-
ated risk factors in Bangladesh, partnering with the International Center for
Diarrheal Disease Research Bangladesh (ICDDR,B) as part of the U.S. Na-
tional Heart, Lung, and Blood Institute collaborating centers of excellence
for chronic diseases. He has been a teaching assistant for several classes at
JHSPH, including Managing Health Services Organizations, Health Systems
OCR for page 101
101
APPENDIX B
in Lower and Middle Income Countries, and Understanding Cost-Effective
Analysis for Healthcare Professionals. Before coming to JHSPH, he worked
for a think tank on health and security and for a consulting firm in Wash-
ington, DC, in the field of occupational health. He received a BS in biomedi-
cal engineering from the University of Virginia in 2006.
Johanna Ralston has been chief executive officer of World Heart Federa-
tion since February 1, 2011. The World Heart Federation, headquartered in
Geneva, comprises more than 200 member organizations in 120 countries
and leads the global fight against heart disease and stroke, with a focus on
low- and middle-income countries. The World Heart Federation is one of
the founding members of the NCD Alliance, the lead civil society organiza-
tion focusing on noncommunicable diseases (NCDs) leading up the United
Nations high-level meeting on NCDs and beyond. Ms. Ralston’s work in
global chronic disease has spanned several organizations, and she has a par-
ticular interest in strengthening local capacity and advocating for integrated
approaches. Prior to joining the World Heart Federation, Ms. Ralston was
vice president, global strategies at the American Cancer Society (ACS). She
joined the ACS in 1999 as its first-ever director of international programs
and development and went on to build a department with training pro-
grams and partnerships in over 80 countries in capacity building, tobacco
control, cancer control advocacy, and, more recently, in global advocacy
with key partners including the World Health Organization and the World
Economic Fund as well as the NCD Alliance. Ms. Ralston’s work in global
health has also included positions as a program development adviser at
the International Planned Parenthood Federation of Latin America and in
advocacy with AIDS organizations in Boston and New York. A dual citizen
of the United States and Sweden, Ms. Ralston has lived and worked in Eu-
rope, Asia, and the United States. She is an alumna of the Harvard Business
School Advanced Management Program, and she has studied public health
at Harvard and Johns Hopkins Bloomberg School of Public Health.
Scott Ratzan, MD, MPA, is vice president of global health at Johnson
& Johnson and editor-in-chief of the Journal of Health Communication:
International Perspectives. Dr. Ratzan is co-chair of the United Nations
Secretary General’s Joint Action Plan on Women and Children’s Health
Innovation Working Group. He presented the pharmaceutical industry
framework on noncommunicable diseases as the International Federation
of Pharmaceutical Manufacturers and Associations representative at the
United Nations interactive hearing in June 2011. He has testified before
the U.S. Congressional Committee on the Millennium Development Goals
concerning opportunities for success with the private sector engagement
in health diplomacy. His books include Mad Cow Crisis: Health and the
OCR for page 102
102 COUNTRY-LEVEL DECISION MAKING
Public Good, Attaining Global Health: Challenges and Opportunities,
and AIDS: Effective Health Communication for the 90s. He received his
MD from the University of Southern California, his MPA from the John
F. Kennedy School of Government at Harvard University, and his MA in
communications from Emerson College.
Karin Stenberg has worked as a health economist at the World Health Or-
ganization (WHO) headquarters in Geneva, Switzerland, since 2004. As a
staff member of the department of child and adolescent health and develop-
ment from 2004 to 2008, she supported models for estimating the cost of
scaling up child health interventions at the global and country levels and
provided support to ministries of health in low-income countries for esti-
mating costs associated with implementing national child health strategies.
Based with the WHO Department of Health Systems Financing since 2008,
she is responsible for the development and application of tools for costing,
cost-effectiveness, and expenditure tracking, with a primary focus on health
systems and WHO’s millennium development goals. She is a member of
the inter-agency working group that is developing the OneHealth model
for supporting country strategic health planning, and she has supported
multiple global cost and impact assessment analyses with advocacy implica-
tions, including the International Health Partnership high-level task force
on innovative international financing for health systems and the global
strategy for women’s and children’s health.
Neff Walker, PhD, is currently a senior scientist in the Department of Inter-
national Health of the Bloomberg School of Public Health at Johns Hopkins
University. At Johns Hopkins, Neff’s work has focused on the development
of the Lives Saved Tool (LiST) a program that is used to estimate the impact
of scaling up interventions on maternal, neonatal, and child mortality. Be-
fore coming to Johns Hopkins he spent three years at UNICEF as the senior
advisor for estimation and modeling related to the impact of HIV/AIDS as
well as serving as UNICEF’s focal point for the Child Health Epidemiology
Reference Group. From 1998 through 2003 Neff worked as the senior advi-
sor for statistics and modeling at United Nations Programme on HIV/AIDS.
In both positions a primary focus of his work was the development and
implementation of standard methods for estimation and modeling related
to disease burden. Prior to working at the United Nations, Neff spent 15
years working as a faculty member in the areas of computer science and
human factors.
Gerald Yonga, MBChB, MMed, MBA, FESC, FACC, is the chair and asso-
ciate professor of medicine and cardiology at Aga Khan University Hospital
in Nairobi, Kenya. He is also the national chair of the Kenya Cardiac So-
OCR for page 103
103
APPENDIX B
ciety and the interim national chair of the Kenya Non-Communicable Dis-
ease Alliance. Dr. Yonga has over 20 years of experience running internal
medicine and cardiology diagnostic and treatment clinics in both the public
and the private sector. His professional mission is to help develop high-
quality accessible health care services, health care workers, institutions, and
health care systems in the East African region. He has lectured extensively
and taught courses on best practices and capacity building in cardiology
to nurses and doctors in the Kenya Ministry of Health, medical students,
and experienced health professionals. Dr. Yonga’s research interests include
the epidemiology, primary and secondary prevention, and primary care of
noncommunicable diseases, and he has published more than 30 articles in
peer-reviewed journals. Dr. Yonga received his MBChB and MMed from
the University of Nairobi and his MBA in health care management from
Regent Business School in Durban, South Africa.
WORKSHOP PLANNING COMMITTEE BIOGRAPHIES1
Rachel A. Nugent, PhD (Chair), is director of the Disease Control Priorities
Network and senior research scientist at the Department of Global Health,
University of Washington. She has 25 years of experience as a develop-
ment economist, managing and carrying out research and policy analysis
in the fields of health, agriculture, and the environment. Prior to joining
the University of Washington, Dr. Nugent was deputy director for global
health at the Center for Global Development. She previously worked at the
Population Reference Bureau, the Fogarty International Center of the U.S.
National Institutes of Health, and the United Nations Food and Agriculture
Organization. She also served as associate professor and chair of the eco-
nomics department at Pacific Lutheran University in Tacoma, Washington.
Dr. Nugent’s recent publications address the cost-effectiveness of noncom-
municable disease interventions, the economic impacts of chronic disease,
and the health impacts of fiscal policies. Dr. Nugent was a committee mem-
ber for the Institute of Medicine study Promoting Cardiovascular Health
in the Developing World: A Critical Challenge to Achieve Global Health.
Kalipso Chalkidou, MD, PhD, is the founding director of the UK National
Institute for Health and Clinical Excellence’s international program, helping
governments build technical and institutional capacity for using evidence
to inform health policy. She is interested in how local information, local
expertise and local institutions can drive scientific and legitimate health care
1 Institute of Medicine planning committees are solely responsible for organizing the work-
shop, identifying topics, and choosing speakers. The responsibility for the published workshop
summary rests with the workshop rapporteur and the institution.
OCR for page 104
104 COUNTRY-LEVEL DECISION MAKING
resource allocation decisions. She has been involved in Chinese rural health
reform and also in national health reform projects in Colombia, Turkey,
and the Middle East, working with the World Bank, the Pan American
Health Organization, the UK Department for International Development,
and the Inter-American Development Bank as well as with national gov-
ernments. She holds a doctorate in molecular biology from the University
of Newcastle and an MD (Hon.) from the University of Athens and is
an honorary senior lecturer at the London School of Hygiene and Tropi-
cal Medicine, a senior advisor on international policy at the U.S. Center
for Medical Technology Policy and visiting faculty at the Johns Hopkins
Berman Institute for Bioethics.
Valentin Fuster, MD, PhD, serves the Mount Sinai Medical Center as
director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardio-
vascular Institute, and the Marie-Josée and Henry R. Kravis Center for
Cardiovascular Health. He is the Richard Gorlin, MD/Heart Research
Foundation Professor at the Mount Sinai School of Medicine. Dr. Fuster
is the general director of the Centro Nacional de Investigaciones Cardio-
vasculares Carlos III in Madrid, Spain. After receiving his medical degree
from Barcelona University and completing an internship at Hospital
Clinic in Barcelona, Dr. Fuster spent several years at the Mayo Clinic,
first as a resident and later as professor of medicine and consultant in car-
diology. In 1981 he came to Mount Sinai School of Medicine as head of
cardiology. From 1991 to 1994 he was Mallinckrodt Professor of Medi-
cine at Harvard Medical School and chief of cardiology at Massachusetts
General Hospital. He returned to Mount Sinai in 1994 as director of the
Zena and Michael A. Wiener Cardiovascular Institute and, most recently,
he has been named the director of Mount Sinai Heart. Dr. Fuster is a past
president of the American Heart Association, immediate past president of
the World Heart Federation, a member of the Institute of Medicine of the
National Academy of Sciences, a former member of the National Heart,
Lung, and Blood Institute Advisory Council, and former chairman of the
fellowship training directors program of the American College of Car-
diology. Twenty-seven distinguished universities throughout the world
have granted Dr. Fuster Honoris Causa. He has published more than 800
articles on the subjects of coronary artery disease, atherosclerosis, and
thrombosis, and he has become the lead editor of two major textbooks
on cardiology and of three books related to health for the public in Spain
(best sellers, presently being translated into English). Dr. Fuster has been
appointed editor-in-chief of the Nature journal that focuses on cardio-
vascular medicine. Dr. Fuster is the only cardiologist to receive all four
major research awards from the four major cardiovascular organizations:
the Distinguished Researcher Award (Interamerican Society of Cardiol-
OCR for page 105
105
APPENDIX B
ogy, 2005), the Andreas Gruntzig Scientific Award (European Society
of Cardiology, 1992), Distinguished Scientist (American Heart Associa-
tion, 2003), and the Distinguished Scientist Award (American College of
Cardiology, 1993). In addition, he has received the Principe de Asturias
Award of Science and Technology (the highest award given to Spanish-
speaking scientists), the Distinguished Service Award from the American
College of Cardiology, the Gold Heart Award (American Heart Associa-
tion’s highest award), and the Gold Medal of the European Society of
Cardiology (the highest award, Vienna, September 2007). Dr. Fuster
has four ongoing projects as part of the World Heart Federation: “Pro-
moting health as a priority” in children of Bogotá with Sesame Street,
“Promoting health as a priority” in adults in the island of Grenada, a
cardiovascular disease polypill developed in Spain for middle- and low-
income countries, and a project with Jeffrey and Sonia Sachs focused on
chronic diseases (as an addition to the Millennium Project) in the African
villages (Rwanda). Dr. Fuster was the committee chair for the IOM study
Promoting Cardiovascular Health in the Developing World: A Critical
Challenge to Achieve Global Health.
Stephen Jan, PhD, is a senior health economist at the George Institute for
Global Health. He also holds an associate professorship in the Sydney
Medical School at the University of Sydney and is an associate at the
Menzies Centre for Health Policy. Dr. Jan’s areas of research interest are
economic evaluation alongside clinical and public health studies, indigenous
health, health systems research, the analysis of the household economic
impact of chronic illness, institutionalist economics, and health policy.
He has published widely in the medical, public health, health policy and
health economics literature and has co-authored two textbooks in health
economics and financing. His current projects are set in China, various
countries in Southeast Asia, and Australia. He is the lead chief investigator
on an Australian National Health and Medical Research Council-funded
capacity-building grant in health services research that provides traineeships
for a number of health economics researchers at the George Institute and
the University of Sydney. Over the course of his career he has acted as an
advisor for numerous local and international agencies, including agencies
within state and national governments in Australia, the World Health Or-
ganization, and the Institute of Medicine (IOM). He was an invited speaker
and was commissioned to author a paper as part of the initial IOM study
Promoting Cardiovascular Health in the Developing World: A Critical
Challenge to Achieve Global Health.
Peter R Lamptey, MD, DrPH, is based in Accra, Ghana, and is the presi-
dent of public health programs at Family Health International (FHI360).
OCR for page 106
106 COUNTRY-LEVEL DECISION MAKING
Dr. Lamptey is an internationally recognized public health physician and
expert in developing countries, with particular emphasis on communicable
and noncommunicable diseases. With a career at FHI spanning more than
25 years, Dr. Lamptey has been instrumental in establishing FHI as one of
the world’s leading international nongovernmental organizations in imple-
menting HIV/AIDS prevention, care, treatment, and support programs. His
experience in HIV/AIDS efforts internationally includes collaboration with
the World Bank to design and monitor the China Health IX HIV/AIDS
Project. From 1997 to 2007 Dr. Lamptey directed the 10-year Implement-
ing AIDS Prevention and Care (IMPACT) project. The IMPACT project
encompassed HIV/AIDS programs in Africa, Asia, Latin America, the Ca-
ribbean, Eastern Europe, and the Middle East. He is the former chair of the
Monitoring the AIDS Pandemic (MAP) Network, a global network of more
than 150 HIV/AIDS experts in 50 countries that was formed in 1996 by
the AIDS Control and Prevention (AIDSCAP) project, the François-Xavier
Bagnoud Center for Health and Human Rights of the Harvard School of
Public Health, and the Joint United Nations Programme on HIV/AIDS. Dr.
Lamptey delivered the HIV prevention plenary speeches at the world AIDS
conferences held in Berlin, Germany, in 1993 and in Durban, South Africa,
in 2000. From 1991 to 1997 Dr. Lamptey directed AIDSCAP, funded by the
U.S. Agency for International Development (USAID) and implemented by
FHI. The largest international HIV/AIDS prevention program undertaken
to date, AIDSCAP consisted of more than 800 projects in 50 countries in
Africa, Asia, Latin America, and the Caribbean. Prior to his work with
AIDSCAP, he directed AIDSTECH, also funded by USAID as a global HIV/
AIDS project and implemented by FHI from 1987 to 1992. Born in Ghana,
Dr. Lamptey began his career as a district medical officer there, first in the
Salaga district, where he was responsible for preventive and clinical health
services for 200,000 individuals, and then for the USAID-funded Danfa
Comprehensive Rural Health Family Planning Project. He received his
medical degree from the University of Ghana, a master’s degree in public
health from the University of California, Los Angeles, and a doctorate in
public health from the Harvard School of Public Health. Dr. Lamptey was
a committee member for the IOM study Promoting Cardiovascular Health
in the Developing World: A Critical Challenge to Achieve Global Health.
Derek Yach, MBChB, DSc, MPH, has played a leading global role in many
aspects of noncommunicable diseases (NCDs) within the private, public,
and foundation world for the past two decades. He is senior vice president
of global health and agricultural policy at PepsiCo. He has headed global
health at the Rockefeller Foundation, been professor of global health at
Yale University, and is a former executive director of the World Health Or-
ganization (WHO). At the WHO he served as cabinet director for non-com-
municable diseases and mental health under Director-General Gro Harlem
OCR for page 107
107
APPENDIX B
Brundtland, during which time he led development of WHO’s Framework
Convention on Tobacco Control, the Global Strategy on Diet and Physical
Activity, and WHO’s World Health Report on Mental Health. Dr. Yach
established the Centre for Epidemiological Research at the South African
Medical Research Council. He has authored or co-authored more than 200
articles covering the breadth of global health. These include leading thought
pieces within NCDs over the last 20 years. He serves on advisory boards of
the Clinton Global Initiative, the Chicago Council on International Affairs’
Agricultural Development Initiative, the World Economic Forum’s New Vi-
sion for Agriculture, the Fogarty International Centre of the U.S. National
Institutes of Health, and the World Food Program USA. He is regular
plenary speaker and moderator of global and national meetings related to
health and development. Dr. Yach has degrees in medicine (Cape Town) and
public health (Johns Hopkins) and an honorary D.Sc. from Georgetown
University. Dr. Yach was a committee member for the IOM study Promot-
ing Cardiovascular Health in the Developing World: A Critical Challenge
to Achieve Global Health.
INSTITUTE OF MEDICINE STAFF BIOGRAPHIES
Bridget B. Kelly, MD, PhD (IOM Project Director), is a senior program
officer with the Institute of Medicine’s Board on Global Health. She was
the study director for the recent report Promoting Cardiovascular Health
in the Developing World: A Critical Challenge to Achieve Global Health,
and continues to direct dissemination efforts for the report. She is also the
study co-director for the congressionally mandated Institute of Medicine
evaluation of U.S. global HIV/AIDS programs. She first came to the Na-
tional Academies in September 2007 as a Christine Mirzayan Science and
Technology Policy Graduate Fellow. Prior to joining the Board on Global
Health in September 2008, she worked on the Board on Children, Youth,
and Families for projects on prevention of mental, emotional, and behav-
ioral disorders among children, youth, and young adults; on depression,
parenting practices, and child development; and on strengthening benefit-
cost methodology for the evaluation of early childhood interventions. She
holds both an MD and a PhD in neurobiology, which she completed as part
of the Medical Scientist Training Program at Duke University. She received
her BA in biology and neuroscience from Williams College, where she was
also the recipient of the Hubbard Hutchinson Fellowship in fine arts. In
addition to her work in science and health, she has more than 10 years of
experience in grassroots nonprofit arts administration.
Collin Weinberger is a research associate at the Institute of Medicine’s
Board on Global Health where he serves as a member of the research staff
for the ongoing dissemination efforts around the 2010 report Promoting
OCR for page 108
108 COUNTRY-LEVEL DECISION MAKING
Cardiovascular Health in the Developing World: A Critical Challenge to
Achieve Global Health as well as for the PEPFAR outcomes and impact
evaluation. He has also served as research staff for the IOM’s Forum on
Microbial Threats. Prior to joining the IOM, he was a communications
associate at Global Health Strategies, a communications and advocacy
consultancy specializing in diseases of the developing world. He also spent
a year as a volunteer with Partners in Health/Socios en Salud in Lima, Peru,
where he worked with the organization’s children’s health, multi-drug-
resistant tuberculosis, and HIV/AIDS programs. He received his bachelor’s
degree in health and societies from the University of Pennsylvania.
Leigh Carroll is a senior program assistant with the Institute of Medicine’s
Board on Global Health. She is involved in dissemination activities for the
2010 report Promoting Cardiovascular Health in the Developing World: A
Critical Challenge to Achieve Global Health, as well as in the evaluation of
PEPFAR-supported global HIV/AIDS programs. Before coming to the IOM,
she spent two years in rural Tanzania teaching high school science through
the Peace Corps. She received her BS in neuroscience from the University
of Rochester in 2008.
Patrick Kelley, MD, DrPH, joined the Institute of Medicine (IOM) in July
2003 as the director of the Board on Global Health. He has subsequently
also been appointed the director of the Board on African Science Academy
Development. Dr. Kelley has overseen a portfolio of IOM expert consensus
studies and convening activities on subjects as wide ranging as the evalu-
ation of the U.S. emergency plan for international AIDS relief, the role of
border quarantine programs for migrants in the 21st century, sustainable
surveillance for zoonotic infections, and the programmatic approach to can-
cer in low- and middle-income countries. He also directs a unique capacity-
building effort, the African Science Academy Development Initiative, which
over 10 years aims to strengthen the capacity of African academies to advise
their governments on scientific matters. Prior to coming to the National
Academies Dr. Kelley served in the U.S. Army for more than 23 years as
a physician, residency director, epidemiologist, and program manager. In
his last Department of Defense (DoD) position, Dr. Kelley founded and
directed the DoD Global Emerging Infections Surveillance and Response
System. This responsibility entailed managing surveillance and capacity
building partnerships with numerous elements of the federal government
and with health ministries in more than 45 developing countries. Dr. Kelley
is an experienced communicator, having lectured in English or Spanish in
more than 20 countries and published more than 64 scholarly papers, book
chapters, and monographs. Dr. Kelley obtained his MD from the University
of Virginia and his DrPH in epidemiology from the Johns Hopkins School
of Hygiene and Public Health.
